- Home
- JMIA vs OPK Comparison
JMIA vs OPK Comparison
Compare JMIA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JMIA | OPK |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | Germany | United States |
| Employees | 2016 | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.2M | 921.2M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | JMIA | OPK |
|---|---|---|
| Price | $7.25 | $1.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $16.75 | $1.60 |
| AVG Volume (30 Days) | ★ 2.8M | 2.3M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $22.18 | N/A |
| Revenue Next Year | $23.26 | $4.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.02 | $0.98 |
| 52 Week High | $14.72 | $1.60 |
Technical Indicators
Market Signals| Indicator | JMIA | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 82.58 |
| Support Level | $7.16 | $1.25 |
| Resistance Level | $9.49 | $1.52 |
| Average True Range (ATR) | 0.43 | 0.06 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 37.29 | 89.41 |
Price Performance
Historical ComparisonAbout JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.